AstraZeneca is investing $2 billion in Maryland, creating 2,600 jobs and expanding its manufacturing facilities in Frederick and Gaithersburg. The Gaithersburg site will focus on developing innovative molecules, while Frederick will nearly double its capacity for existing medications, including rare disease treatments. This is Marylands largest private investment in a decade, with the state contributing a 10% match. The Frederick expansion will bring 200 skilled positions and 900 construction roles, while Gaithersburg will add 100 jobs, retain 400 current roles, and support 1,000 construction jobs. Both facilities are expected to be operational by 2029.

The Daily News Now! — Every city. Every story. AI-powered.

---

Hosted on Acast. See acast.com/privacy for more information.